April 26, 2018/Neurosciences/Research

How Long to Monitor with cEEG? New Data Help Shape Choices

Large study gives guidance based on mental status, seizure etiology

18-NEU-823-Hantus-EEG-650×450

Among hospitalized patients requiring continuous EEG (cEEG) monitoring, those in a stuporous state and those with seizures due to hemorrhage, trauma or tumor are most likely to have delayed seizure detection and warrant longer cEEG monitoring. So concludes a large retrospective Cleveland Clinic study presented at the 2018 annual meeting of the American Academy of Neurology (AAN).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The findings represent a needed step toward better defining the optimal duration of cEEG monitoring according to patient characteristics and seizure etiology, explains the study’s senior author, Cleveland Clinic epileptologist Stephen Hantus, MD. “It’s now fairly widely recognized that there is a subpopulation of hospitalized patients who experience nonconvulsive seizures in the setting of another medical illness,” he says. “What we’re missing is the next step. How do you make smart choices about how long to monitor different patients to maximize detection of nonconvulsive seizures and actually improve care?”

Study backdrop

Recognition of the prevalence of nonconvulsive seizures among hospitalized patients has emerged from several investigations in recent years, Dr. Hantus notes. One was an analysis by Cleveland Clinic’s cEEG monitoring group of 1,000 inpatients who underwent cEEG observation in 2009-2010; the aim was to determine who was at greatest risk for seizures. The researchers found that seizure detection rates increased in a linear fashion according to patient mental status — from 6 percent in patients with awake status to 20 percent with lethargic status to 25 percent with stupor to 33 percent with coma. The study also identified several high-risk etiologies for seizures: Stroke was most common, followed by hemorrhage, tumor, venous infection and approximately 25 less-common etiologies.

“This helped identify who should be monitored,” Dr. Hantus says. “But we have a limited number of monitoring machines, so we needed data-based guidance on how long to keep at-risk patients hooked up to a monitor.”

What the present analysis found

That’s where the current study comes in, which reviewed data for all inpatients at Cleveland Clinic’s main campus who underwent cEEG monitoring in 2016 (N = 2,425).

Among these 2,425 patients, 334 had seizures detected during monitoring. Median time to seizure onset was 3 hours, and 39 percent had their first seizure within an hour of monitoring. Nearly 14 percent had status epilepticus on cEEG.

For most seizure etiologies, at least 50 percent of patients had their seizures detected within the first 6 hours of cEEG monitoring. Seizures were detected within 24 hours among 80 percent of patients except those whose seizures were secondary to hemorrhage, trauma or tumor. Seizures were detected within 36 hours among 90 percent of patients except those whose seizures were due to hemorrhage, tumor or an unknown etiology.

Advertisement

Among all seizure etiologies, hemorrhage was the one most likely to be associated with seizure detection after 24 hours, particularly if a patient had more than one hemorrhage type.

When findings were evaluated according to patients’ mental status, seizures were detected within 2 days in 90 percent of patients who were awake, lethargic or comatose, whereas it took more than 3 days of monitoring for seizure detection in 90 percent of patients who were stuporous.

Overall, comatose patients and those with seizures secondary to cardiac arrest were most likely to have their seizures detected early.

Helpful guidance before and after discharge

“These findings suggest that if patients have one of these high-risk characteristics, such as stupor or hospitalization for hemorrhage (particularly more than one hemorrhage type), tumor or trauma, they merit longer cEEG monitoring to help ensure we’re not missing potential nonconvulsive seizures,” says Dr. Hantus.

He adds that more-intensive monitoring in these high-risk groups may also help flag patients at risk for epilepsy down the road, as about 50 percent of inpatients who have certain high-risk nonconvulsive seizure patterns such as periodic lateralized epileptiform discharges (PLEDs) during hospitalization will develop epilepsy after discharge. “We believe that longer cEEG monitoring in appropriate groups can allow us to improve long-term care and follow-up as well.”

Another study looks closer at hemorrhage

In a separate study presented as a poster at the AAN meeting, Dr. Hantus and Cleveland Clinic colleagues took a deeper dive into one of the patient subtypes touched upon in the first study — hospitalized patients with intraparenchymal hemorrhage (IPH) who were monitored with cEEG.

Advertisement

“Among types of intraparenchymal hemorrhage, cortical hemorrhage is well recognized as a risk factor for nonconvulsive seizures, but the seizure risk posed by subcortical hemorrhages, which are far more common, is less clear,” Dr. Hantus notes.

To better define these risks, his team did a retrospective chart review of 121 patients with IPH who underwent brain CT or MRI as well as cEEG monitoring at Cleveland Clinic from January 2013 to December 2014. They found that a significant share of patients with IPH and seizures on cEEG had subcortical hemorrhages, accounting for 28 percent of cases with seizures and an abnormal EEG (defined as PLEDs).

“Subcortical intraparenchymal hemorrhage is a common form of IPH and often overlooked in terms of seizure risk, perhaps because most patients with subcortical IPH recover quite well,” says Dr. Hantus. “Yet these findings show that patients with supratentorial IPH, specifically subcortical IPH, should be evaluated for subclinical seizures, to help ensure that seizures get addressed properly if detected.”

Related Articles

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022/Neurosciences/Research
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022/Neurosciences/Research
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

20-NEU-1959738 powered-exoskeleton-for-gait-training_650x450
October 23, 2020/Neurosciences/Research
Study Signals Potential of Powered Exoskeleton for Gait Training in Multiple Sclerosis

Pilot findings show good patient acceptance and safety, early hints of efficacy

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
October 21, 2020/Neurosciences/Research
Electronic Screening for Sleep Disorders Among Healthcare Workers Is Feasible – and Sorely Needed

Study finds high prevalence of symptoms, willingness to seek treatment

20-NEU-1946228 neurofilaments_650x450
September 9, 2020/Neurosciences/Research
Serum Neurofilament Light as a Progressive MS Biomarker: Guideposts for the Road Ahead

Panel outlines research priorities around a promising alternative to imaging markers

20-NEU-1951118_Impella-temporary-LVAD_650x450_ (1)
September 4, 2020/Neurosciences/Research
Study Finds Clues to Acute Neurologic Events With Short-Term Impella Cardiac Support

Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia

20-NEU-1929179 deep-brain-stimulation-for-TBI_650x450
September 3, 2020/Neurosciences/Research
Could DBS of the Cerebellar Dentate Nucleus Enhance Post-TBI Rehabilitation?

Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury

Ad